分享资源・传播知识

QQ登录

微信登录

账号登录没有账号？扫码注册

分享资源・传播知识

QQ注册

微信注册

« 返回已有账号？去登录

分享资源・传播知识

微信扫码登录

您的位置：外唐网 > 文档大全

全部分类

行业资料

(10w+ 篇文档)

3金币 CMIC：2022年真实世界数据：在日本实现患者处方旅程的数字化报告（英文版）.PDF

...

内容提供方：外唐用户 | 2025-08-02 发布 | 2.24MB | 5 页
3金币 CMIC：2022年现实世界数据如何革新罕见肿瘤药物开发报告（英文版）.PDF

...

内容提供方：外唐用户 | 2025-08-02 发布 | 324.38KB | 7 页
3金币 CMIC：2019年在药物开发新时代中定制生物分析测试报告（英文版）.PDF

All of this again favors strategic partnerships with specialist service providers, basedless on size than on flexible and responsive expertise. “Client needs are changing inthat respect," Suga comments.“Our clients tend to be relatively entre...

内容提供方：外唐用户 | 2025-08-01 发布 | 5.39MB | 9 页
5金币 CMIC：2012年全球生物分析委员会（GCC）对新欧洲药品管理局生物分析方法验证指南的解释建议白皮书（英文版）.PDF

Senior representatives of GCC member companies have thoroughly evaluated and discussed the new European Medicines Agency (EMA; July 2011 [1]) Guideline on Bioanalytical Method Validation (BMV), during the 4th GCC (23 October 2011, Washington DC, U...

内容提供方：外唐用户 | 2025-08-01 发布 | 3.96MB | 10 页
5金币 CMIC：2011年关于内部标准准则、稳定性、已发生的样品重新分析和全球生物分析合同研究组织委员会最近的483s的建议报告（英文版）.PDF

During the 2nd Closed Forum, it was reiterated that the GCC is unique since it is the companies that are members rather than individuals and each is equal within the organization (i.e., there is no hierarchical structure). In an effort to accommod...

内容提供方：外唐用户 | 2025-08-01 发布 | 2.13MB | 10 页
3金币 CMIC：2021年亚洲之门：日本和韩国的市场准入白皮书（英文版）.PDF

asia offers rich opportunities forpharmaceutical companies seekingalternatives to the mature markets inNorth America or Europe. Two essentialpillars of the region are japan and South Korea.Both have been progressively opening up to theglobalizatio...

内容提供方：外唐用户 | 2025-08-01 发布 | 2.21MB | 9 页
3金币 CMIC：2020年数字疗法的兴起：构建未来报告（英文版）.PDF

Digital therapeutics (DTx) are evolving rapidly. any now provide drug-like mechanisms of action thatdeliver greater value to both standalone solutions and therapies that pair DTx with prescription drugsTo succeed in the market, companies must attr...

内容提供方：外唐用户 | 2025-08-01 发布 | 258.16KB | 8 页
3金币 CMIC：2020年在不确定时期管理制造报告（英文版）.PDF

Virtual pharmaceutical companies often have strong regulatory and clinical teams, but often they lackthe resources needed to address the complexities of the complete product development and com-mercialization cycle. Partnering with a contract develop...

内容提供方：外唐用户 | 2025-08-01 发布 | 222.9KB | 7 页
3金币 CMIC：2020年快速变化的研发流程如何放大可适应的CRO的重要性白皮书（英文版）.PDF

Major advances in our understanding of the causes of once-untreatable diseases have reshaped the global drug development pipeline over the past decade, paving the way for better health outcomes for many millions of people. To realize these emergin...

内容提供方：外唐用户 | 2025-08-01 发布 | 1.1MB | 9 页
3金币 CMIC：C-PRESS公共关系杂志-第16卷（英文版）.PDF

Nakamura Since the end of the Second World War, the average lifetime has increased rapidly in Japan and the Japanese have the longest life expectancy in the world. Establishment of world-class, excellent systems, such as a universal health insuran...

内容提供方：外唐用户 | 2025-08-01 发布 | 9.34MB | 7 页
8金币 CMIC：2020年强化的CMO关系为赞助商扩展机会报告（英文版）.PDF

Key strategies that can lead to a win-win relationship include a relationshipon a solid foundation, softfactors, and project managementexcellence. This article discussesthese strategies as well as FDAguidelines on quality agreementsfor the contrac...

内容提供方：外唐用户 | 2025-08-01 发布 | 4.66MB | 30 页
5金币 CMIC：2020年早期药物开发报告（英文版）.PDF

While pivotal clinical trials remain critical to securing the approvalsrequired for the launch of new drugs, it is interesting and also encouraging to observe acommon thread running through some recent regulatory and policy discussions.
That...

内容提供方：外唐用户 | 2025-08-01 发布 | 5.87MB | 18 页
5金币 CMIC：2013年全球合同研究组织委员会（GCC）关于已使用样品稳定性（ISS）的建议白皮书（英文版）.PDF

The topic of Incurred Sample Stability (lSS) has generated considerable discussion within thebioanalytical community in recent years. The subject was an integral part of the 7" annualWorkshop on Recent lssues in Bioanalysis (WRlB) held in Lon...

内容提供方：外唐用户 | 2025-08-01 发布 | 5.13MB | 11 页
5金币 CMIC：2011年GCC关于生物分析方法稳定性对联合给药和联合配方药物影响的建议白皮书（英文版）.PDF

In 2010, the global bioanalytical community learned of regulatory agency concern of the potential for co-administered compounds present in a bioanalytical matrix to impact the stability of analytes subject to bioanalytical measurement. This pertai...

内容提供方：外唐用户 | 2025-08-01 发布 | 612.63KB | 11 页
5金币 CMIC：2019年亚洲临床试验报告（英文版）.PDF

there is no longer any excuse not toinclude japan as an integral part of anyglobal clinical-development programfor either pharmaceuticals or medicaldevices. With a more receptive climatefor both starting and running trials, an improvedinfrastructu...

内容提供方：外唐用户 | 2025-08-01 发布 | 2.45MB | 20 页
8金币 CMIC：2017年全球临床试验的变革之面：亚太地区成为专业生物制药的理想目的地白皮书（英文版）.PDF

The contract research organization (CRO) marketin the Asia-Pacific (APAC) region is the fastest-growing in the world, with revenue expected toincrease at a 20% compound annual growth rate(CAGR) from 2016 to 202l compared with therest of the world&...

内容提供方：外唐用户 | 2025-08-01 发布 | 1.49MB | 32 页
3金币 CMIC：2018年如何在日本成功进行临床试验白皮书（英文版）.PDF

There is no longer any excuse not to include Japan as an integral part of any globalclinical-development program for either pharmaceuticals or medical devices. With amore receptive climate for both starting and running trials, an improved infrastr...

内容提供方：外唐用户 | 2025-08-01 发布 | 227.32KB | 9 页
5金币 CMIC：2019年药物开发与制造：挑战与机遇报告（英文版）.PDF

QUESTION :In 2007, CMIc acquired a manufacturingplant in New Jersey. That early acquisition became CMICCMO USA, a contract service provider for oral solid drugmanufacturing. What has changed for the Us part of thecompany?
MAKOTO MATSUKAWA: T...

内容提供方：外唐用户 | 2025-08-01 发布 | 877.8KB | 15 页
8金币水井坊：2021年环境、社会、公司治理（ESG）报告.PDF

...

内容提供方：外唐用户 | 2025-07-31 发布 | 17.59MB | 57 页
10金币水井坊：2022年环境、社会、公司治理（ESG）报告.PDF

...

内容提供方：外唐用户 | 2025-07-31 发布 | 15.15MB | 62 页

«
1
2
...
7
8
9
10
11
...
424
425
»

外唐智库 | 计算机教程 | Photoshop教程 | 魔方网 | 考研辅导 | 博维教育 | 外语学习 | 公务员辅导 | 司法考试 | 瑜伽教程 | 企业年报库 | 营销方案 | 房地产策划 | 数字化转型 | w3School | 报告合集 | BootWiki